Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Laboratories (CLB) Share-based Compensation (2022 - 2026)

Core Laboratories filings provide 5 years of Share-based Compensation readings, the most recent being $5.0 million for Q1 2026.

  • On a quarterly basis, Share-based Compensation rose 20.99% to $5.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $8.0 million, a 158.89% increase, with the full-year FY2025 number at $7.1 million, up 90.07% from a year prior.
  • Share-based Compensation hit $5.0 million in Q1 2026 for Core Laboratories, up from $1.1 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $9.0 million in Q1 2023 to a low of -$475000.0 in Q3 2024.
  • Median Share-based Compensation over the past 5 years was $1.4 million (2023), compared with a mean of $2.2 million.
  • Biggest five-year swings in Share-based Compensation: crashed 129.27% in 2024 and later skyrocketed 507.58% in 2025.
  • Core Laboratories' Share-based Compensation stood at $304000.0 in 2022, then soared by 414.8% to $1.6 million in 2023, then crashed by 129.27% to -$458000.0 in 2024, then soared by 343.23% to $1.1 million in 2025, then soared by 351.71% to $5.0 million in 2026.
  • The last three reported values for Share-based Compensation were $5.0 million (Q1 2026), $1.1 million (Q4 2025), and $1.3 million (Q3 2025) per Business Quant data.